Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intranasal Fluticasone Propionate in Chronic Sinusitis
NCT01623323Phase 3Completed
- Sponsor
- OptiNose
- Start
- Sep 2013
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in sinusitis, sponsored by OptiNose. Started Sep 2013; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT01623323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623323.